CLL and its tissue counterpart, small lymphocytic lymphoma (SLL), represent mature B-cell neoplasms characterized by the progressive accumulation of immunophenotypically aberrant CD5+CD19+CD23+ B lymphocytes. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.